Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Stanford University
TILT Biotherapeutics Ltd.
Ossium Health, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
Herlev Hospital
H. Lee Moffitt Cancer Center and Research Institute
Herlev Hospital
University of Pittsburgh
City of Hope Medical Center
Case Comprehensive Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
University of Nebraska
BGI, China
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Karolinska University Hospital
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Mie University
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
University Health Network, Toronto
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Herlev Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
University Health Network, Toronto
Roswell Park Cancer Institute